CIHR Project Grants (Sept 2022 Intake)

Frank Beier, and Silvia Penuela, PhD $100,000 for "The role of Pannexin 3 in aging-associated osteoarthristis."

Dimitros J. Dikeakos, PhD and co-applicants Gregory A. Dekaban, PhD, and Bradley L. Urquhart, PhD $944,775 over 5 years for "Mechanisms of cell surface protein regulation by the HIV-1 accessory proteins Nef and Vpu."

David W. Holdsworth, PhD along with co-applicants Aaron Fenster, PhD, and Muriel Brackstone, MD $807,075 over 5 years for "Combined gamma probe and ultrasound imaging system for cancer surgery."

Pingzhao Hu, PhD $100,000 for "Artificial Intelligence-empowered approaches towards the development of combination therapies for HER2+/ER+ breast cancer."

Anthony C. Nichols, MD $990,675 for 5 years for "Targeted and immuno-therapy to overcome innate and acquired resistance in aggressive MAPK-addicted cancers."

Silvia Penuela, PhD and co-applicant, John Ronald, PhD $971,550 over 5 years for "Targeting Pannexin-1- Channels in Glioblastoma Multiforme."

Christopher L. Pin, PhD and Parisa Shooshtari, PhD along with co-applicants Kenneth Leslie, MD, and Stephen A. Welch, MD $100,000 for "Tumour cell reprogramming in pancreatic ductal adenocarcinoma as a means for therapeutic resistance."

Lisa Porter, PhD $745,875 over 5 years for "Role of Cyclin-Like Proteins in Regulating the Regenerative Balance in the Liver; Implications in Fatty Liver Disease and Hepatocellular Carcinoma."
Eileen Rakovitch, MD (Sunnybrook) and Michael Hallett, PhD $1,981,352 over 4 years for "Validation of a novel biomarker classifier that predicts radiation response following breast-conserving surgery for ductal carcinoma in situ (DCIS)."

Caroline Schild-Poulter, PhD and Nathalie G. Bérubé, PhD $100,000 for "Investigating the molecular pathology of WDR26 deficiency."